What was GeneFirst-Emerging's revenue for February 2026?

GeneFirst-Emerging's revenue for February 2026 was NT$35,863 thousand, which is approximately NT$36 million.

How did GeneFirst-Emerging's February 2026 revenue compare to the previous year?

GeneFirst-Emerging's revenue in February 2026 showed a year-over-year increase of 12.0%.

What is the stock code for GeneFirst-Emerging?

The stock code for GeneFirst-Emerging is 6645.

In which industry does GeneFirst-Emerging operate?

GeneFirst-Emerging operates in the Biotechnology and Medical Care industry.

What specific month and year does the reported revenue data pertain to?

The reported revenue data pertains to the month of February in the year 2026.

AI News NQ Analysis

[GeneFirst-Emerging] February 2026 Revenue: NT$36 Million (YoY +12.0%)

NQ Score 50/100

N1 Content Completeness 3

AI Summary (NQ-processed)

GeneFirst-Emerging announced its revenue for February 2026 reached NT$36 million, a 12.0% increase year-over-year. The revenue figures for the biotechnology company, which specializes in precision medicine, demonstrate stable growth in its genetic testing services business.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What was GeneFirst-Emerging's revenue for February 2026?: A: GeneFirst-Emerging's revenue for February 2026 was NT$35,863 thousand, which is approximately NT$36 million.
Q: How did GeneFirst-Emerging's February 2026 revenue compare to the previous year?: A: GeneFirst-Emerging's revenue in February 2026 showed a year-over-year increase of 12.0%.
Q: What is the stock code for GeneFirst-Emerging?: A: The stock code for GeneFirst-Emerging is 6645.
Q: In which industry does GeneFirst-Emerging operate?: A: GeneFirst-Emerging operates in the Biotechnology and Medical Care industry.
Q: What specific month and year does the reported revenue data pertain to?: A: The reported revenue data pertains to the month of February in the year 2026.